Alexander Haragan

Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response

Alexander Haragan, John K. Field, Michael P.A. Davies et al. · Lung Cancer · 2019 · 177 citations · Full text

Medicine, Immunology, Oncology +17

Domain Adaptation-Based Deep Learning for Automated Tumor Cell (TC) Scoring and Survival Analysis on PD-L1 Stained Tissue Images

Ansh Kapil, Armin Meier, Keith E. Steele et al. · IEEE Transactions on Medical Imaging · 2021 · 36 citations · Full text

Veterinary Medicine, Oncology, Pathology +17

Accelerated instability testing reveals quantitative mass spectrometry overcomes specimen storage limitations associated with PD-L1 immunohistochemistry

Alexander Haragan, D.C. Liebler, Dimple M. Das et al. · Laboratory Investigation · 2020 · 29 citations · Full text

Life Sciences, Molecular Biology, Pathology +17

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

D.C. Liebler, Timothy R. Holzer, Alexander Haragan et al. · Scientific Reports · 2020 · 27 citations · Full text

Life Sciences, Immunology, Oncology +17

Programmed death ligand 1 expression in EBUS aspirates of non–small cell lung cancer: Is interpretation affected by type of fixation?

John R. Gosney, Alexander Haragan, Claire Chadwick et al. · Cancer Cytopathology · 2019 · 23 citations · Full text

Medicine, Oncology, Pathology +16